欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
Cefmatilen_140128-74-1_产品详情
140128-74-1
  • names:

    (6R,7R)-3-((((1H-1,2,3-triazol-4-yl)thio)methyl)thio)-7-((Z)-2-(2-aminothiazol-4-yl)-2-(hydroxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

  • CAS号:

    140128-74-1

    MDL Number:
  • MF(分子式): C15H14N8O5S4 MW(分子量): 514.56
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
Cefmatilen
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
FMK13196-100mg 100mg >98% ¥ 0.00 ¥ 0.00 Get quote
- +
¥ 0.00
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名 Cefmatilen
英文别名 Cefmatilen; S 1090; S-1090; S1090;
CAS号 140128-74-1
Inchi InChI=1S/C15H14N8O5S4/c16-15-18-5(2-30-15)8(21-28)11(24)19-9-12(25)23-10(14(26)27)6(3-29-13(9)23)31-4-32-7-1-17-22-20-7/h1-2,9,13,28H,3-4H2,(H2,16,18)(H,19,24)(H,26,27)(H,17,20,22)/b21-8-/t9-,13-/m1/s1
InchiKey UEQVTKSAEXANEZ-YCRCPZNHSA-N
分子式 Formula C15H14N8O5S4
分子量 Molecular Weight 514.56
溶解度Solubility
性状 Solid powder
储藏条件 Storage conditions Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).
产品说明 Cefmatilen(CAS:140128-74-1):仅限应用于工业或者科学研究过程中非医疗目的,不应用于人类或动物的临床诊断以及治过程疗,该产品非药用,非食用。
IntroductionCefmatilen is a compound being developed as a cephalosporin antibiotic for oral use.
Application1
Application2
Application3
警示图
危险性 Warning
危险性警示
安全声明
安全防护
备注
[1]Takeuchi M, Harada M, Nagata M, Watanabe A, Nakamura K. [Immunological properties of S-1090, cefmatilen hydrochloride hydrate]. J Toxicol Sci. 2001 May;26 Suppl 1:231-42. Japanese. PubMed PMID: 11400315.
[2]Yahara I, Furukawa H, Sato K, Nishimura K, Harihara A, Yabuuchi K, Miyauchi H, Kii Y, Muraoka Y, Kitamura T, Kato I. [Toxicity study of cefmatilen hydrochloride hydrate (S-1090) (1)--Single oral and intravenous dose toxicity studies in rats]. J Toxicol Sci. 2001 May;26 Suppl 1:1-4. Japanese. PubMed PMID: 11400306.
[3] Kishi K, Andou M, Muraoka Y, Ito M, Hara K, Yoshida T, Muranaka R, Kanamori S, Hirashiba M, Uchida H, Kawai M, Ikeuchi K, Hishikawa A, Kaneto M. [Reproductive and developmental toxicity studies of S-1090, cefmatilen hydrochloride hydrate (4)--A study on oral administration during the perinatal and lactation periods in rats]. J Toxicol Sci. 2001 May;26 Suppl 1:205-29. Japanese. PubMed PMID: 11400314.
[4] Sameshima H, Omori M, Nishimura Y, Chihaya Y, Itoh F, Mizushima Y, Yabuuchi K, Ohno K, Furukawa H, Yoshida I, Ueno M, Yahara I, Kato I. [Toxicity study of cefmatilen hydrochloride hydrate (S-1090) (5)--Six-month repeated oral dose toxicity study and supplement study in rats]. J Toxicol Sci. 2001 May;26 Suppl 1:77-108. Japanese. PubMed PMID: 11400319.
[5] Hara K, Muraoka Y, Yoshida T, Muranaka R, Kanamori S, Hirashiba M, Uchida H, Ikeuchi K, Kawai M, Hishikawa A, Kaneto M, Kishi K. [Reproductive and developmental toxicity studies of S-1090, cefmatilen hydrochloride hydrate (1)--A study on oral administration prior to and in the early stages of pregnancy in rats]. J Toxicol Sci. 2001 May;26 Suppl [5]157-70. Japanese. PubMed PMID: 11400311.
6: Nishino I, Fujitomo H, Umeda T. Determination of a new oral cephalosporin, cefmatilen hydrochloride hydrate, and its seven metabolites in human and animal plasma and urine by coupled systems of ion-exchange and reversed-phase high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl. 2000 Nov 10;749(1):101-10. PubMed PMID: 11129069.7: Kondo K, Takase S, Nishimoto Y, Miyajima H, Shiratori O, Miyake Y. [Genotoxicity studies of cefmatilen hydrochloride hydrate (S-1090)]. J Toxicol Sci. 2001 May;26 Suppl 1:243-54. Japanese. PubMed PMID: 11400316.8: Kato I, Nishimura K, Ueno M, Inoue S, Harihara A, Yabuuchi K, Sato K, Miyauchi H, Hirata M, Kimura Y, Furukawa H. [Toxicity study of cefmatilen hydrochloride hydrate (S-1090) (2)--Single oral dose toxicity study in dogs]. J Toxicol Sci. 2001 May;26 Suppl 1:5-12. Japanese. PubMed PMID: 11400318.9: Sameshima H, Ueda T, Haruyama E, Chihaya Y, Mizushima Y, Ueno M, Moriyama T, Kii Y, Kato I. [Toxicity study of cefmatilen hydrochloride hydrate (S-1090) (6)--Six-month repeated oral dose toxicity study in dogs]. J Toxicol Sci. 2001 May;26 Suppl 1:109-34. Japanese. PubMed PMID: 11400307.10: Yahara I, Yamagata H, Ueno M, Inoue S, Sato K, Nishimura K, Miyauchi H, Hirata M, Muraoka Y, Kimura Y, Kitamura T, Kato I. [Toxicity study of cefmatilen hydrochloride hydrate (S-1090) (4)--One- and three-month repeated oral dose toxicity studies in dogs]. J Toxicol Sci. 2001 May;26 Suppl 1:43-76. Japanese. PubMed PMID: 11400317.1
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻

        怎么做细胞爬片免疫组化染色实验

        细胞爬片免疫组化染色,是通过细胞爬片是让玻片浸在细胞培养基内,细胞在玻片上生长,主要用于组织学,免疫组织化学...

        2020/7/20 22:04:33

        提取病毒RNA的实验方法

        提取病毒RNA方法分别有:异硫氰酸胍的提取病毒RNA方法、TRIzol LS提取法、Trizol法提取法等等...

        2020/7/22 20:29:26

        细胞培养耗材技术领先性

        细胞培养板行业面临的核心痛点是:常规TC处理后表面亲水角随时间衰减,影响长期培养稳定性,BIOFOUNT高分...

        2026/4/28 15:12:51

        细胞培养耗材关键性能

        细胞培养板的水接触角作为表面润湿性的核心指标,直接影响细胞贴壁、增殖、分化及功能表达,其中40°(低接触角/...

        2026/4/28 14:52:44

        chelex 100树脂国产替代之路-BIOFOUNT范德生物

        Chelex 100螯合离子交换树脂对铜、铁和其他重金属?的偏好显著高于对钠、钾等一价阳离子的偏好。它对二价...

        2025/11/4 14:22:46

        9月开学季——助研新学期 范德送好礼

        2025/8/28 15:30:55

        Waxfilm 实验室封口膜:技术与国际市场的双重突破

        在实验室耗材领域,封口膜是保障实验准确性与稳定性的关键产品之一。近年来,Waxfilm?实验室封口膜凭借其卓...

        2025/5/13 13:03:40

        Waxfilm实验室封口膜的5大突破

        Waxfilm实验室封口膜作为生物功能膜领域的国产技术突破和品牌突破,是生物领域中国技术发展的缩影。

        2025/5/6 17:02:07

        各种微流控芯片键合方法的优缺点

        微流控芯片键合:目前主要有激光焊接、热压键合、胶键合、超音波焊接,每种方法都有各自的优缺点。本文主要介绍聚酯...

        2023/7/28 10:43:09

        新一代微流控键合解决方案

        微流控键合解决方案:微流控芯片制造的一个重要环节,也是最容易被忽视的--芯片键合。其中一个重要因素是:微流控...

        2023/7/27 12:44:28

        My title page contents